Alice Fabarius
III. Medizinische Klinik
Medizinische Fakultät Mannheim der Universität Heidelberg
Mannheim
Wiesbadener Strasse 7-11
Germany
[email]@*.ma.uni-heidelberg.de
Name/email consistency: high
- Centrosome aberrations and G1 phase arrest after in vitro and in vivo treatment with the SRC/ABL inhibitor dasatinib. Fabarius, A., Giehl, M., Rebacz, B., Krämer, A., Frank, O., Haferlach, C., Duesberg, P., Hehlmann, R., Seifarth, W., Hochhaus, A. Haematologica (2008)
- Centrosome aberrations after nilotinib and imatinib treatment in vitro are associated with mitotic spindle defects and genetic instability. Fabarius, A., Giehl, M., Frank, O., Spiess, B., Zheng, C., Müller, M.C., Weiss, C., Duesberg, P., Hehlmann, R., Hochhaus, A., Seifarth, W. Br. J. Haematol. (2007)
- Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failure. Fabarius, A., Haferlach, C., Müller, M.C., Erben, P., Lahaye, T., Giehl, M., Frank, O., Seifarth, W., Hehlmann, R., Hochhaus, A. Haematologica (2007)
- Induction of centrosome and chromosome aberrations by imatinib in vitro. Fabarius, A., Giehl, M., Frank, O., Duesberg, P., Hochhaus, A., Hehlmann, R., Seifarth, W. Leukemia (2005)